MLchartDataset catalogue

ET 743

Term · Oncology and biomedicine · MLC-T-ONC-003008

A drug used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have spread to other parts of the body. It is used in patients who have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. ET 743 may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called ecteinascidin, trabectedin, and Yondelis.

Table 1. Record
IdentifierMLC-T-ONC-003008
FieldOncology and biomedicine
Synonymsecteinascidin; trabectedin; Yondelis
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003008",
  "term": "ET 743",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have spread to other parts of the body. It is used in patients who have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. ET 743 may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called ecteinascidin, trabectedin, and Yondelis.",
  "synonyms": [
    "ecteinascidin",
    "trabectedin",
    "Yondelis"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/et-743/"
}

Record 6,943 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.